Calcium channel blockers
AssigneeNeuromed Pharmaceuticals Ltd.
InventorsTerrance Snutch, Gerald Zamponi
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeuromed Pharmaceuticals Ltd.
InventorsTerrance Snutch, Gerald Zamponi
Estimating the term…
Compounds of the formula wherein m is 0, 1 or 2; wherein when m is 0, Z is O, when m is 1, Z is N, and when m is 2, Z is C; Y is H, OH, NH2, or an organic moiety of 1-20 C, optionally additionally containing 1-8 heteroatoms selected from the group consisting of N, P, O, S and halo; each 11 1 and 12 is independently 0-5; 13 is O or 1; each of R1, R2 and R3 is independently alkyl (1-6 C), aryl (6-10 C) or arylalkyl (7-16 C) optionally containing 1-4 heteroatoms selected from the group consisting of halo, N, P, O, and S or each of R1 and R2 may independently be halo, COOR, CONR2, CF3, CN or NO2, wherein R is H or lower alkyl (1-4 C) or alkyl (1-6 C); n is 0 or 1; X is a linker; with the proviso that Y is not a tropolone, a coumarin, or an antioxidant containing an aromatic group and with the further proviso that if 13 is 0, and either 11 and 12 is 0 or 1 and if R1 and/or R2 represent F in the para position, Z cannot be C or N; and are useful to treat pain. Libraries of these compounds can also be used to identify antagonists for other targets.
A method to treat pain in a subject which method comprises administering to a subject in need of such treatment a compound of the formula
A pharmaceutical composition for use in treating pain which composition comprises, in admixture with a pharmaceutically acceptable excipient, a dosage amount of a compound of the formula
3-5. (canceled)
Dependencies are inferred from the claim text.